Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions

Drug-drug interactions (DDI) potentially occurring between medications used in the course of COVID-19 infection and medications prescribed for the management of underlying comorbidities may cause adverse drug reactions (ADRs) contributing to worsening of the clinical outcome in affected patients. Fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Awortwe, Charles, Cascorbi, Ingolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550259/
https://www.ncbi.nlm.nih.gov/pubmed/33059010
http://dx.doi.org/10.1016/j.phrs.2020.105250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550259/
https://www.ncbi.nlm.nih.gov/pubmed/33059010
http://dx.doi.org/10.1016/j.phrs.2020.105250

Ejemplares similares